Drug intelligence / Profile preview

irvingia gabonensis extract

Development stage
Unknown
Lead developer
Gateway Health Alliances
Administration
Oral
01

Overview

Irvingia gabonensis extract, commonly known as African mango, is a botanical extract derived from the seeds of the West African tree *Irvingia gabonensis*. It is primarily utilized as a dietary supplement for weight management and metabolic health. The most clinically studied standardized version is IGOB131. The extract contains active polyphenolic compounds, including ellagic acid and its derivatives. Its mechanism of action involves the modulation of adipogenesis and lipid metabolism by down-regulating the expression of peroxisome proliferator-activated receptor gamma (PPARγ) and leptin genes, while up-regulating adiponectin. Clinical trials have investigated its efficacy in treating obesity, metabolic syndrome, and hyperlipidemia, though evidence quality is often cited as limited due to methodological concerns.

Brand names
Integra-Lean African Mango IrvingiatruDERMA MangodrinVitacost African Mango Extract IGOB131 Certified
Other names
African mango extractIrvingia gabonensis seed extractDika nut extractOgbono
02

Targets

PPARG (Peroxisome proliferator-activated receptor gamma)AdipoR (Adiponectin receptor)LEP (Leptin)

Beyond the preview

Go deeper on irvingia gabonensis extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on irvingia gabonensis extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call